Polianta LTD Repligen Corp Transaction History
Polianta LTD
- $213 Million
- Q3 2024
Shares
2 transactions
Others Institutions Holding RGEN
# of Institutions
486Shares Held
54.3MCall Options Held
341KPut Options Held
235K-
Black Rock Inc. New York, NY7.57MShares$1.08 Billion0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD6.39MShares$911 Million0.11% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.04MShares$719 Million0.01% of portfolio
-
State Street Corp Boston, MA1.62MShares$232 Million0.01% of portfolio
-
Champlain Investment Partners, LLC Burlington, VT1.42MShares$203 Million1.34% of portfolio
About REPLIGEN CORP
- Ticker RGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 55,491,200
- Market Cap $7.91B
- Description
- Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....